Mahe Bouquet

Mrs. Mahe Bouquet

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2019 in Intensive Care Medicine Experimental
Verified
Journal Article
Open access
PDF file
KKKatrina K. Ki
Katrina K. Ki
MPMargaret Passmore
Margaret Passmore
CCChris H. H. Chan
Chris H. H. Chan
Maximilian Valentin MalfertheinerMaximilian Valentin Malfertheiner
Maximilian Valentin Malfertheiner
JFJonathon P. Fanning
Jonathon P. Fanning
JSJacky Suen
Jacky Suen
Extracorporeal membrane oxygenation (ECMO) is a life-saving modality used to manage cardiopulmonary failure refractory to conventional medical and surgical therapies. Despite advances in ECMO equipment, bleeding and thrombosis remain significant complications. While the flow rate for ECMO support is well recognized, less is known about the minimum-rate requirements and haemostasis. We investigated the relationship between different ECMO flow rates, and their effect on haemolysis and coagulation. Ten ex-vivo ECMO circuits were tested using donated, < 24-h-old human whole blood, with two flow rates: high-flow at 4 L/min (normal adult cardiac output; n = 5) and low-flow at 1.5 L/min (weaning; n = 5). Serial blood samples were taken for analysis of haemolysis, von Willebrand factor (vWF) multimers by immunoblotting, rotational thromboelastometry, platelet aggregometry, flow cytometry and routine coagulation laboratory tests. Low-flow rates increased haemolysis after 2 h (p = 0.02), 4 h (p = 0.02) and 6 h (p = 0.02) and the loss of high-molecular-weight vWF multimers (p = 0.01), while reducing ristocetin-induced platelet aggregation (p = 0.0002). Additionally, clot formation times were prolonged (p = 0.006), with a corresponding decrease in maximum clot firmness (p = 0.006). In an ex-vivo model of ECMO, low-flow rate (1.5 L/min) altered haemostatic parameters compared to high-flow (4 L/min). Observed differences in haemolysis, ristocetin-induced platelet aggregation, high-molecular-weight vWF multimers and clot formation time suggest an increased risk of bleeding complications. Since patients are often on ECMO for protracted periods, extended-duration studies are required to characterise long-term ECMO-induced haemostatic changes.

1 November 2020 in Journal of Immunological Methods
Verified
Journal Article
Closed access
MBMahe Bouquet
Mahe Bouquet
MPMargaret Passmore
Margaret Passmore
LHLouise See Hoe
Louise See Hoe
JTJohn-Paul Tung
John-Paul Tung
GSGabriela Simonova
Gabriela Simonova
John Francis FraserJohn Francis Fraser
John Francis Fraser

25 April 2021 in Membranes
Verified
Journal Article
Open access
PDF file
Chris Hoi Houng ChanChris Hoi Houng Chan
Chris Hoi Houng Chan
KKKatrina K. Ki
Katrina K. Ki
MZMeili Zhang
Meili Zhang
CACooper Asnicar
Cooper Asnicar
HCHwa Jin Cho
Hwa Jin Cho
John Francis FraserJohn Francis Fraser
John Francis Fraser
In vitro hemolysis testing is commonly used to determine hemocompatibility of ExtraCorporeal Membrane Oxygenation (ECMO). However, poor reproducibility remains a challenging problem, due to several unidentified influencing factors. The present study investigated potential factors, such as flow rates, the use of anticoagulants, and gender of blood donors, which could play a role in hemolysis. Fresh human whole blood was anticoagulated with either citrate (n = 6) or heparin (n = 12; 6 female and 6 male blood donors). Blood was then circulated for 360 min at 4 L/min or 1.5 L/min. Regardless of flow rate conditions, hemolysis remained unchanged over time in citrated blood, but significantly increased after 240 min circulation in heparinized blood (p ≤ 0.01). The ratio of the normalized index of hemolysis (NIH) of heparinized blood to citrated blood was 11.7-fold higher at 4 L/min and 16.5–fold higher at 1.5 L/min. The difference in hemolysis between 1.5 L/min and 4 L/min concurred with findings of previous literature. In addition, the ratio of NIH of male heparinized blood to female was 1.7-fold higher at 4 L/min and 2.2-fold higher at 1.5 L/min. Our preliminary results suggested that the choice of anticoagulant and blood donor gender could be critical factors in hemolysis studies, and should be taken into account to improve testing reliability during ECMO.

15 July 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
WKWildi Karin
Wildi Karin
MBMahe Bouquet
Mahe Bouquet
CACarmen Ainola
Carmen Ainola
SLSamantha Livingstone
Samantha Livingstone
SCSebastiano Maria Colombo
Sebastiano Maria Colombo
John Francis FraserJohn Francis Fraser
John Francis Fraser
Despite decades of comprehensive research, Acute Respiratory Distress Syndrome (ARDS) remains a disease with high mortality and morbidity worldwide. The discovery of inflammatory subphenotypes in human ARDS provides a new approach to study the disease. In two different ovine ARDS lung injury models, one induced by additional endotoxin infusion (phenotype 2), mimicking some key features as described in the human hyperinflammatory group, we aim to describe protein expression among the two different ovine models. Nine animals on mechanical ventilation were included in this study and were randomized into (a) phenotype 1, n = 5 (Ph1) and (b) phenotype 2, n = 4 (Ph2). Plasma was collected at baseline, 2, 6, 12, and 24 h. After protein extraction, data-independent SWATH-MS was applied to inspect protein abundance at baseline, 2, 6, 12, and 24 h. Cluster analysis revealed protein patterns emerging over the study observation time, more pronounced by the factor of time than different injury models of ARDS. A protein signature consisting of 33 proteins differentiated among Ph1/2 with high diagnostic accuracy. Applying network analysis, proteins involved in the inflammatory and defense response, complement and coagulation cascade, oxygen binding, and regulation of lipid metabolism were activated over time. Five proteins, namely LUM, CA2, KNG1, AGT, and IGJ, were more expressed in Ph2.

1 April 2020 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
LHLouise See Hoe
Louise See Hoe
MWM.A. Wells
M.A. Wells
MBMahe Bouquet
Mahe Bouquet
KHK. Hyslop
K. Hyslop
MPMargaret Passmore
Margaret Passmore
John Francis FraserJohn Francis Fraser
John Francis Fraser

3 March 2023 in JACC
Verified
Journal Article
Closed access
KSKei Sato
Kei Sato
SHSilver Heinsar
Silver Heinsar
KWKarin Susanne Wildi
Karin Susanne Wildi
NONchafatso Gikenyi Obonyo
Nchafatso Gikenyi Obonyo
KLKeibun Liu
Keibun Liu
John Francis FraserJohn Francis Fraser
John Francis Fraser